期刊文献+

多参数流式细胞术在多发性骨髓瘤早期诊断中的应用价值 被引量:18

Value of multiparameter flow cytometry in the early diagnosis of multiple myeloma
原文传递
导出
摘要 目的分析探讨多参数流式细胞术在多发性骨髓瘤(MM)早期诊断中的价值。方法回顾性分析64例MM确诊患者初诊时,流式细胞术、骨髓涂片细胞形态学检查、血清蛋白电泳和免疫固定电泳等实验室检查结果,比较各结果阳性率及在MM早期诊断、分型中的优劣。结果 64例MM患者中62例(96.88%)经流式细胞术检出异常浆细胞(a PC);56例(87.50%)血清免疫固定电泳呈阳性,其中Ig G型占35.94%,Ig A型占18.75%,轻链型占29.69%。45例细胞形态学检查见骨髓瘤细胞,比例为7.5%~90.0%,相对应的流式细胞术检出的瘤细胞比例为1.17%~72.31%,两者呈正相关(r=0.755,P〈0.01)。4种方法对MM的检出率差异有统计学意义(χ2=20.04,P〈0.01)。结论多参数流式细胞术是MM早期诊断最敏感方法,但4种方法结合将更有利于诊断。 Objective To investigate the value of multiparameter flow cytometry( MFC) in the early diagnosis of multiple myeloma( MM). Methods Retrospectively analyze the detection results of FC,BM smear cytomorphology,serum protein electrophresis( SPE) and immunofixation electrophoresis( IFE) of 64 patients with MM confirmed,and to compare and analyze the positive detection ratio and the advantages and limitations of these methods in the early diagnosis and typing of MM. Results Aberrant plasma cells( a PC) were detected from 62 cases( 96. 88%) by MFC among 64 patients; 56 cases( 87. 50%) had positive results by IFE,the frequency of immunoglobulin typing showed: Ig G accounted for 35. 94%,Ig A accounted for 18. 75%,and light- chain- only accounted for 29. 69%; myeloma cells were examined from 45 cases by cell morphology,and the proportion was among 7. 5%- 90. 0%,the correspondent MFC proportion was among 1. 17%- 72. 31%. They showed a positive correlation with each other( r = 0. 755,P〈 0. 01). There was statistical significance on the differences in positive detection rates of MM with these four methods( χ2= 20. 04,P〈 0. 01). Conclusion MFC is the most sensitive method in the early diagnosis of multiple myeloma,but the combination of these methods will be more conductive to diagnosis.
出处 《中国卫生检验杂志》 CAS 2016年第2期236-239,243,共5页 Chinese Journal of Health Laboratory Technology
关键词 多发性骨髓瘤 流式细胞术 形态学 血清蛋白电泳 免疫固定电泳 Multiple myeloma Flow cytometry Cytomorphology Serum protein electrophresis Immunofixation electrophoresis
作者简介 唐洁(1981-),女,硕士,主治医师,主要从事临床血液检验诊断方面的研究。
  • 相关文献

参考文献11

  • 1Group IMW. Criteria for the classification of monoclonal gammopa- thies, multiple myeloma and related disorders : a report of the Inter- national Myeloma Working Group[J].Br J Haematol, 2003, 121 (5) : 749 -757.
  • 2Rawstron AC, Orfao A, Beksac M, et al. Report of the European Myeloma Network on multiparametric flow cytometry in multiple my- eloma and related disorders [J].Haematologica, 2008, 93 ( 3 ) : 431 - 438.
  • 3中国多发性骨髓瘤诊治指南(2013年修订)[J].中华内科杂志,2013,52(9):791-795. 被引量:149
  • 4Paiva B, Almeida J, Perez - Andres M, et al. Utility of flow cy- tometry immunophenotyping in multiple myeloma and other clonal plasma cell - related disorders [ J ]. Clinical Cytometry, 2010, 78 (4) : 239 -252.
  • 5Kyle RA, Rajkumar SV. Multiple myeloma [ J ]. N Engl J Med, 2004, 351(18) : 1860 -1873.
  • 6李娟,赵莹,罗绍凯,黄蓓晖,张国材,彭爱华,郑冬,苏畅,许多荣,童秀珍,谷景立,丁艳.223例新诊断多发性骨髓瘤临床特点及疗效分析[J].中华医学杂志,2008,88(30):2140-2143. 被引量:21
  • 7Kumar S, Kimlinger T, Morice W. Immunophenotyping in multiple myeloma and related plasma cell disorders [ J ]. Best Pract Res Clin Haematol, 2010, 23(3) : 433 -451.
  • 8Tatsas AD, Jagasia MH, Chen H, et al. Monitoring residual myelo- ma: high - resolution serum/urine electrophoresis or marrw biopsy with immunobistochemical analysis? [ J]. Am J Clin Pathol, 2010, 134(1) : 139 -144.
  • 9Davies FE, Rawstren AC, Owen RG, et al. Minimal residual dis-ease monitoring in multiple myeloma [J]. Best Pract Res Clin Haematol, 2002, 15(1): 197-222.
  • 10Biran N, Ely S, Chari A. Controversies in the assessment of mini- mal residuai disease in multiple myeloma: clinical significance of minimal residual disease negativity using highly sensitive techniques [J]. Curr Hematol Malig Rep, 2014, 9(4) : 368 -378.

二级参考文献8

  • 1麦玉洁,邱录贵,李睿,靳风艳,白洁,万长春,王建祥,季林祥,肖志坚,钱林生.432例多发性骨髓瘤临床分析[J].白血病.淋巴瘤,2004,13(4):198-201. 被引量:28
  • 2陶中飞,傅卫军,陈玉宝,袁振刚,王东星,侯健.206例多发性骨髓瘤预后因素分析及分期评价[J].癌症,2006,25(4):461-464. 被引量:45
  • 3武永吉.多发性骨髓瘤//张之南,沈悌,血液病诊断及疗效标准,3版.北京:科学出版社,2007:232-235.
  • 4Blade J, SamsonD, Reece D, et al. Criteria for evaluating disease response and progression in patients with multiple myeloma treated by high dose therapy and hemopoietic stem cell transplantation. Myeloma Subcommittee of the EMBT. european group for blood and marrow transplant. Br J Haematol, 1998,102 : 1115-1123.
  • 5Kyle RA, Gertz MA, Witzig TE, et al. Review of 1027 patients with newly diagnosed multiple myeloma. Mayo Clin Proc, 2003, 78:21-33.
  • 6Blade J, Lust JA, Kyle RA. Immunoglobulin D multiple myeloma: Presenting features, response to therapy, and survival in a series of 53 cases. J Clin Oncol, 1994, 12:2398-2404.
  • 7Shimamoto Y, Anami Y, Yamaguchi M. A new risk grouping for IgD myeloma based on analysis of 165 Japanese patients. Eur J Haematol, 1991,47:262-267.
  • 8庄俊玲,武永吉,钟玉萍,何坚,沈悌,张之南.多发性骨髓瘤218例临床分析[J].中国实用内科杂志,2004,24(2):108-110. 被引量:61

共引文献168

同被引文献105

引证文献18

二级引证文献66

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部